Pharmacy Times
DECEMBER 24, 2024
Pharmacists can significantly improve chronic obstructive pulmonary disease (COPD) management by promoting non-pharmacological interventions.
Drug Topics
DECEMBER 24, 2024
Check out this list of our top 5 most read COVID-19 stories from the year 2024.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmacy Times
DECEMBER 24, 2024
Factors associated with intravenous immunoglobulin (IVIG)-related adverse events include older age, dehydration, and administration of multiple IVIG infusions.
Drug Topics
DECEMBER 24, 2024
Jennifer Goldman, PharmD, CDCES, BC-ADM, FCCP, professor of pharmacy practice at Massachusetts College of Pharmacy and Health Sciences, discuses the benefits of glucagon.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Pharmacy Times
DECEMBER 24, 2024
The monoclonal antibody demonstrates the ability to reduce the incidence and improve symptoms related to sleep disorders and psychiatric disorders such as anxiety.
pharmaphorum
DECEMBER 24, 2024
Sanofi has moved ahead with plans to challenge Pfizer and MSD for a piece of the market for pneumococcal vaccines.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
pharmaphorum
DECEMBER 24, 2024
AstraZeneca's EGFR inhibitor Tagrisso has become the first drug in the class to be approved in the EU for a form of early-stage lung cancer.
Pharmacy Times
DECEMBER 24, 2024
Researchers recommend early vaccination against herpes zoster to mitigate the risks.
pharmaphorum
DECEMBER 24, 2024
The FDA has wrapped up a series of new approvals as 2024 draws to a close, with Novo Nordisk, Pfizer, Vertex, and Hikma among the beneficiaries.
Pharmacy Times
DECEMBER 24, 2024
In this episode of Public Health Matters, Christina Madison discusses the concept of reproductive justice and ensuring Black maternal health efforts are not left behind with Regina Davis Moss of In Our Own Voice.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
pharmaphorum
DECEMBER 24, 2024
AstraZeneca and Daiichi Sankyo have decided to voluntarily withdraw their EU marketing application for Dato-DXd in lung cancer.
Pharmaceutical Technology
DECEMBER 24, 2024
XBiotech has said it will investigate the results of its rheumatoid arthritis trial after finding irregularities in its Phase II trial.
Pharmacy Times
DECEMBER 24, 2024
Pharmacists are encouraged to work closely with health care providers to ensure appropriate use of high-cost Intravenous immunoglobulin (IVIG) therapy for BK nephropathy.
Pharmaceutical Technology
DECEMBER 24, 2024
This seed funding comes after GEMMABio secured $100m in October through a partnership with Brazilian supplier Fiocruz.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Pharmacy Times
DECEMBER 24, 2024
Pharmacists bring a unique perspective to health care that bridges clinical knowledge, patient-centered care, and operational expertise.
Pharmaceutical Technology
DECEMBER 24, 2024
RAPT Therapeutics and Shanghai Jemincare Pharmaceutical have signed an exclusive agreement for RPT904 to treat various allergic conditions.
Pharmacy Times
DECEMBER 24, 2024
Of these chemicals, 414 were found to be commonly used in plastics and consumer goods, such as food packaging and personal care products.
Pharmaceutical Technology
DECEMBER 24, 2024
The FDA initially rejected the marketing application for Alhemo in 2022, asking for additional data on dosing and monitoring.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
pharmaphorum
DECEMBER 24, 2024
Discover the current status of digitalisation in clinical trials and its impact on the industry. Explore the progress and challenges of moving towards digitised clinical trial processes.
Pharmaceutical Technology
DECEMBER 24, 2024
AstraZeneca has gained approval from the European Commission for its oral therapy, Tagrisso (osimertinib), to treat adults with NSCLC.
PharmExec
DECEMBER 24, 2024
Approval marks the first generic version of liraglutide injection, referencing Victoza, for improving glycemic control in adults and children aged 10 years and older with type 2 diabetes, alongside diet and exercise.
Pharmaceutical Commerce
DECEMBER 24, 2024
The latest news for pharma industry insiders.
PharmExec
DECEMBER 24, 2024
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
pharmaphorum
DECEMBER 24, 2024
Explore the latest perspectives on cell therapies for autoimmune disease treatment post-ACR 2024 and how they are transforming therapy options.
Pharmaceutical Commerce
DECEMBER 24, 2024
The Drug Supply Chain Security Act was a major coverage area for Pharma Commerce in 2024.
PharmExec
DECEMBER 24, 2024
In this part of his Pharmaceutical Executive video interview, Peter Ax, CEO of UpScriptHealth, shares some specific examples of how AI is being used to personalize treatment plans, monitor patient progress, and identify potential issues.
Pharmacy Times
DECEMBER 24, 2024
Patient education on the risks of the long-term illness can help overcome vaccine hesitancy.
OctariusRx
DECEMBER 24, 2024
Merry Christmas! Thank you to our clients, family, and friends for all your support this year. Our entire team is grateful for our blessings and the wonderful people we work with. Whether you joined us this December, or have been with us for many years, thank you for allowing us to take care of you. We appreciate your trust and support. A successful year would be impossible without our hardworking team.
STAT
DECEMBER 24, 2024
Retractions are a sign that science is working as it should. When papers turn out to be flawed, journals typically correct the record to stem the spread of incorrect information and clarify that the other work in their catalogue can be trusted. In just one recent high-profile example, the International Journal of Antimicrobial Agents this week retracted a controversial paper on hydroxychloroquine as an effective treatment for Covid-19 that had drawn ample criticism over methodological and
STAT
DECEMBER 24, 2024
In the wake of the tragic murder of UnitedHealthcare CEO Brian Thompson, all of us who serve in health care must take time to pause and reflect on how we move forward. As a religious sister and leader of the Catholic Health Association of the United States, my reflection on this tragedy has called me to think more deeply about the season of Advent and the meaning of Christmas.
STAT
DECEMBER 24, 2024
Blood stem cell transplants have been central players in treating blood cancers for decades. These procedures can improve patients’ chances of survival and can even offer the opportunity for a cure in some cases. But over the last decade, physicians say they’ve started doing transplants for fewer cancer types, particularly lymphomas, and are instead reaching first for newer immune or targeted therapies that are safer and often more effective.
STAT
DECEMBER 24, 2024
Midway through 2024, the bottom fell out of telehealth in the United States — or so it felt like to casual observers of the industry. Within a single week, both Walmart and UnitedHealth’s Optum were reported to shut down their virtual care services, closely following the surprise departure of Teladoc’s longtime CEO in April. Telehealth, the rising star of online-first health care set in motion by the necessity of the pandemic, seemed to be in free fall.
Expert insights. Personalized for you.
122 
Let's personalize your content